These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 31226545)

  • 1. Emotional expressions associated with therapeutic inertia in multiple sclerosis care.
    Saposnik G; Oh J; Terzaghi MA; Kostyrko P; Bakdache F; Montoya A; Jaja BNR; Nisenbaum R; Ruff CC; Tobler PN
    Mult Scler Relat Disord; 2019 Sep; 34():17-28. PubMed ID: 31226545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Physician Therapeutic Inertia for Management of Patients With Multiple Sclerosis in Canada, Argentina, Chile, and Spain.
    Almusalam N; Oh J; Terzaghi M; Maurino J; Bakdache F; Montoya A; Caceres F; Saposnik G
    JAMA Netw Open; 2019 Jul; 2(7):e197093. PubMed ID: 31314113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision-making in Multiple Sclerosis: The Role of Aversion to Ambiguity for Therapeutic Inertia among Neurologists (DIScUTIR MS).
    Saposnik G; Sempere AP; Prefasi D; Selchen D; Ruff CC; Maurino J; Tobler PN
    Front Neurol; 2017; 8():65. PubMed ID: 28298899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Inertia in Multiple Sclerosis Care: A Study of Canadian Neurologists.
    Saposnik G; Montalban X; Selchen D; Terzaghi MA; Bakdache F; Montoya A; Fruns M; Caceres F; Oh J
    Front Neurol; 2018; 9():781. PubMed ID: 30319523
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of an Educational Intervention on Therapeutic Inertia in Neurologists With Expertise in Multiple Sclerosis: A Randomized Clinical Trial.
    Saposnik G; Grueschow M; Oh J; Terzaghi MA; Kostyrko P; Vaidyanathan S; Nisenbaum R; Ruff CC; Tobler PN
    JAMA Netw Open; 2020 Dec; 3(12):e2022227. PubMed ID: 33326024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).
    Saposnik G; Sempere AP; Raptis R; Prefasi D; Selchen D; Maurino J
    BMC Neurol; 2016 May; 16():58. PubMed ID: 27146451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Prescribing Generic (Non-proprietary) Drugs in the Prevalence of Therapeutic Inertia in Multiple Sclerosis Care.
    Saposnik G; Mamdani M; Terzaghi M; Saladino ML; Silva B; Tobler PN; Caceres F
    Front Neurol; 2018; 9():835. PubMed ID: 30369904
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioral aspects of nurse practitioners associated with optimal multiple sclerosis care in Spain.
    Saposnik G; Del Río B; Bueno-Gil G; Sempere ÁP; Lendínez-Mesa A; Rodríguez-Antigüedad A; Terzaghi M; Medrano N; Maurino J
    PLoS One; 2021; 16(12):e0261050. PubMed ID: 34879095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with therapeutic inertia among pharmacists caring for people with multiple sclerosis.
    Terzaghi MA; Ruiz C; Martínez-López I; Pérez-Encinas M; Bakdache F; Maurino J; Saposnik G
    Mult Scler Relat Disord; 2020 Apr; 39():101887. PubMed ID: 31846865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Decision-Making Under Uncertainty in the Management of Spinal Muscular Atrophy: Results From DECISIONS-SMA Study.
    Saposnik G; Camacho A; Díaz-Abós P; Brañas-Pampillón M; Sánchez-Menéndez V; Cabello-Moruno R; Terzaghi M; Maurino J; Málaga I
    Neurol Ther; 2022 Sep; 11(3):1209-1219. PubMed ID: 35657490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming Therapeutic Inertia in Multiple Sclerosis Care: A Pilot Randomized Trial Applying the Traffic Light System in Medical Education.
    Saposnik G; Maurino J; Sempere AP; Terzaghi MA; Ruff CC; Mamdani M; Tobler PN; Montalban X
    Front Neurol; 2017; 8():430. PubMed ID: 28871238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialists.
    Saposnik G; Andhavarapu S; Fernández Ó; Kim HJ; Wiendl H; Foss M; Zuo F; Havrdová EK; Celius EG; Caceres F; Magyari M; Bermel R; Costa A; Terzaghi M; Kalincik T; Popescu V; Amato MP; Montalban X; Oh J
    Mult Scler Relat Disord; 2022 Jan; 57():103389. PubMed ID: 35158479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Decisions in Atrial Fibrillation for Stroke Prevention: The Role of Aversion to Ambiguity and Physicians' Risk Preferences.
    Sposato LA; Stirling D; Saposnik G
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2088-2095. PubMed ID: 29650382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint study.
    Saposnik G; Andhavarapu S; Fernández Ó; Kim HJ; Wiendl H; Foss M; Zuo F; Havrdová EK; Celius E; Caceres F; Magyari M; Bermel R; Costa A; Terzaghi M; Kalincik T; Popescu V; Amato MP; Montalban X; Oh J
    Mult Scler Relat Disord; 2022 Feb; 58():103404. PubMed ID: 35216786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognizing Emotional Expression as an Outcome Measure After Face Transplant.
    Dorante MI; Kollar B; Obed D; Haug V; Fischer S; Pomahac B
    JAMA Netw Open; 2020 Jan; 3(1):e1919247. PubMed ID: 31940037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial Emotion Recognition and Expression in Parkinson's Disease: An Emotional Mirror Mechanism?
    Ricciardi L; Visco-Comandini F; Erro R; Morgante F; Bologna M; Fasano A; Ricciardi D; Edwards MJ; Kilner J
    PLoS One; 2017; 12(1):e0169110. PubMed ID: 28068393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinician Facial Expression of Emotion Corresponds with Patient Mindset.
    Versluijs Y; Moore MG; Ring D; Jayakumar P
    Clin Orthop Relat Res; 2021 Sep; 479(9):1914-1923. PubMed ID: 33835095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care.
    Saposnik G; Mamdani M; Montalban X; Terzaghi M; Silva B; Saladino ML; Tobler PN; Caceres F
    MDM Policy Pract; 2019; 4(1):2381468319855642. PubMed ID: 31259250
    [No Abstract]   [Full Text] [Related]  

  • 19. That "poker face" just might lose you the game! The impact of expressive suppression and mimicry on sensitivity to facial expressions of emotion.
    Schneider KG; Hempel RJ; Lynch TR
    Emotion; 2013 Oct; 13(5):852-66. PubMed ID: 23795586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-emotion facial expression aftereffects.
    Pell PJ; Richards A
    Vision Res; 2011 Sep; 51(17):1889-96. PubMed ID: 21763713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.